On Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
On Sept. 24, 2025, Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs announced they will sell generic versions…
On Sept. 22, 2025, The Gates Foundation will give $912 million to the Global Fund to Fight AIDS,…
On Jul. 14, 2025, The World Health Organization (WHO) released new guidelines recommending the use of injectable lenacapavir…
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
On May 8, 2025, Bill Gates announced that he has decided to give away his money back to…
On Feb. 5, 2025, the proposed dismantling of the U.S. Agency for International Development (USAID) could disrupt clinical…
On Nov. 26, 2024, the the United Nations reported that fewer people contracted HIV last year than at…
On Jul. 25, 2024, the World Health Organization (WHO) announced during the 25th International AIDS Conference, being held…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge…
On Mar. 25, 2021, about two decades after first devising a new kind of vaccine, Oregon Health &…
On Nov. 18, 2020, Gilead Sciences announced topline results from the Phase 2/3 CAPELLA trial evaluating the company’s…
On Sept. 2, 2020, UT Southwestern (UTSW) announced that it had performed the first HIV-positive-to-HIV-positive organ transplant in…
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
On Mar. 14, 2006, Providence Health & Services and the Institute for Systems Biology (ISB) announced an affiliation…
On May 31, 2015, the New England Primate Research Center (NEPRC) closed its doors. During its five decades…
On Sept. 3, 2014, Oregon Health & Science University (OHSU) announced it had been awarded a $25 million…
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
On Mar. 10, 2010, National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) was established as a nationwide initiative…
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…
In 2002, Stanford geneticist Mark Kay uses a gene-therapy technique known as RNA inhibition to switch off genes…